A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...
Texas DPS launches a groundbreaking program letting sexual assault survivors test DNA free of charge, even if a report has ...
Biological age tests promise insights into aging, but are they accurate or useful? What science shows about benefits, limits, ...
Prosecutors at Brian Walshe’s murder trial continued Tuesday to present evidence they say proves he killed his wife around New Year’s Day 2023 at their Massachusetts home.
DNA can sustain serious injuries called double strand breaks, in which both strands of the helix snap. These breaks are among ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns in 1,154 healthy individuals has been published in ...
A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...
A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...
Medical Device Network on MSN

Natera purchases Foresight Diagnostics

Cell-free DNA and precision medicine company Natera has acquired Foresight Diagnostics, a business known for its ...
Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...
An Austin, Texas-based genetics-testing company that specializes in cell-free DNA and precision medicine has acquired Foresight Diagnostics Inc., a Boulder-based cancer-diagnostics company.